How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Veterinary Rapid Test Kit Market
- By Animal Type: Companion Animals, Livestock, Poultry, Aquatic Animals, Equine
- By Test Type: Immunochromatographic Assays, Enzyme-Linked Immunosorbent Assays (ELISA), Lateral Flow Assays, Agglutination Tests, Molecular Rapid Tests (PCR-based)
- By Disease Type: Infectious Diseases, Parasitic Diseases, Metabolic Disorders, Reproductive Disorders, Nutritional Deficiencies
- By End User: Veterinary Hospitals and Clinics, Diagnostic Laboratories, Farm and Livestock Facilities, Research Institutes, Retail Pharmacies
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Companion Animals leads By Animal Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 284 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.170 →
- 11 Company Profiles 16 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Veterinary Rapid Test Kit Market report
A complete, evidence-based study - 11 chapters and 119 sections covering market size, segmentation across 4 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Animal Type 5
Test Type 5
Disease Type 5
End User 5
Companies profiled
Zoetis Inc.
IDEXX Laboratories Inc.
Abaxis
Inc. (a Zoetis company)
Thermo Fisher Scientific Inc.
Boehringer Ingelheim International GmbH
Merial (now part of Boehringer Ingelheim)
Biogal-Galed Labs Ltd.
Agdia Inc.
BioNote Inc.
VETSCAN (Zoetis)
Neogen Corporation
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Zoetis Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →IDEXX Laboratories Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Abaxis
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Inc. (a Zoetis company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Thermo Fisher Scientific Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Boehringer Ingelheim International GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Merial (now part of Boehringer Ingelheim)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Biogal-Galed Labs Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Agdia Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →BioNote Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →VETSCAN (Zoetis)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Neogen Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Mast Group Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Avacta Animal Health Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Heska Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Qingdao Yizheng Biological Technology Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,478M by 2033 · 6.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Companion Animals29.3
- Livestock16.3
- Poultry20.2
- Aquatic Animals17.9
- Equine16.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$917.5M → $1,347M · 4.9%
Europe$639.5M → $969.5M · 5.3%
Asia Pacific$583.9M → $1,023M · 7.3%
Latin America$361.4M → $554.7M · 5.5%
Middle East and Africa$278.0M → $448.8M · 6.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.082026
6.102027
6.112028
6.132029
6.142030
6.142031
6.172032
6.172033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Zoetis Inc.18.1
- IDEXX Laboratories Inc.24.4
- Abaxis6.4
- Inc. (a Zoetis company)5.4
- Thermo Fisher Scientific Inc.12.4
- Boehringer Ingelheim International GmbH5.3
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Animal Type23.7%
Test Type23.2%
Disease Type16.5%
End User36.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.0
- Europe22.3
- Asia Pacific23.5
- Latin America12.8
- Middle East and Africa10.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Zoetis Inc. | 89 | 83 | 86 | 91 | 97 | 89 | 89 |
| IDEXX Laboratories Inc. | 68 | 93 | 83 | 83 | 92 | 80 | 83 |
| Abaxis | 69 | 83 | 77 | 77 | 68 | 83 | 76 |
| Inc. (a Zoetis company) | 68 | 72 | 71 | 66 | 64 | 79 | 70 |
| Thermo Fisher Scientific Inc. | 76 | 75 | 69 | 53 | 75 | 63 | 69 |
| Boehringer Ingelheim International GmbH | 65 | 65 | 52 | 54 | 46 | 67 | 58 |
| Merial (now part of Boehringer Ingelheim) | 58 | 52 | 53 | 63 | 63 | 56 | 58 |
| Biogal-Galed Labs Ltd. | 57 | 43 | 37 | 54 | 36 | 48 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Zoetis Inc.
- IDEXX Laboratories Inc.
- Abaxis
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Zoetis Inc. | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| IDEXX Laboratories Inc. | ◐ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Abaxis | − | ✓ | ✓ | ◐ | ◐ | ◐ |
| Inc. (a Zoetis company) | − | ✓ | ✓ | ✓ | ◐ | ◐ |
| Thermo Fisher Scientific Inc. | ◐ | ◐ | − | ◐ | ◐ | ◐ |
| Boehringer Ingelheim International GmbH | ◐ | − | ◐ | ◐ | − | ◐ |
| Merial (now part of Boehringer Ingelheim) | − | − | − | ◐ | ◐ | − |
| Biogal-Galed Labs Ltd. | ◐ | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Zoetis Inc.89
2IDEXX Laboratories Inc.83
3Abaxis76
4Inc. (a Zoetis company)70
5Thermo Fisher Scientific Inc.69
6Boehringer Ingelheim International GmbH58
7Merial (now part of Boehringer Ingelheim)58
8Biogal-Galed Labs Ltd.46
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Zoetis Inc.IDEXX Laboratories Inc.
Challenger3
Strong scale, closing on the leaders.
AbaxisInc. (a Zoetis company)Thermo Fisher Scientific Inc.
Contender2
Focused players with pockets of strength.
Boehringer Ingelheim International GmbHMerial (now part of Boehringer Ingelheim)
Niche1
Specialists in a single segment or region.
Biogal-Galed Labs Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Animal Type in North America, then scale across Veterinary Rapid Test Kit Market — a $232M beachhead inside a $3.78B market.
Beachhead (SOM)$232Mobtainable near-term
Serviceable (SAM)$1.50Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Companion Animals
Best fit — highest urgency & budget in Animal Type.
Economic buyer76 fit
Livestock
Strong fit — clear ROI and a fast path to value.
End user69 fit
Poultry
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Animal Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Test Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Disease Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel29%
Digital / self-serve18%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Animal Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Veterinary Rapid Test Kit Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified24%
Evaluation12%
Closed-won7%
$11.8KCAC
$67KLTV
5.7:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Veterinary Rapid Test Kit Market is a resilient opportunity — $3.60B by 2033, compounding at 4.9%.
TAM · 2025$2.46Btoday
TAM · 2033$3.60Bforecast
CAGR4.9%2027–2033
Cumulative$27.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.60BTotal addressable market
SAM$1.51BServiceable available market
SOM$308MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.9% CAGR
Demand compounds through 2033, outpacing GDP across Animal Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Animal Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.60BLarge & growingTAM by 2033 at 4.9% CAGR
$1.51BServiceable nowreachable with today’s model
$308MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.81BBear3.2% CAGR
$3.60BBase4.9% CAGR
$4.61BBull6.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Test Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Veterinary Rapid Test Kit Market — a $5.34B market by 2033. Plan: grow share from 6.5% to 11.4%.
Market size · 2033$5.34Btotal addressable
Market CAGR9.8%2027–2033
Target share11.4%from 6.5% today
Revenue ambition$609Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.5% | 11.4% | At risk |
| Revenue | $319M | $609M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 30.3% | 45.9% | Ahead |
| Customer retention | 89.6% | 95.1% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Animal Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Test Type capability
A defensible second engine — invest in Test Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Animal Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Test Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $85M capacity & capability investment
- Greenlight bolt-on M&A in Test Type
- Authorise North America expansion plan
- Fund R&D program for Animal Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Veterinary Rapid Test Kit Market conversation — a $2.85B market you can size, segment and defend in minutes.
Market size · 2033$2.85Btotal opportunity
Growth7.5%CAGR to 2033
Addressable buyers976+accounts in scope
Typical ROI5.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Animal Type
Goal Grow share in Animal Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.7×return on cost, year one
< 3 mopayback period
$52K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Zoetis Inc.IDEXX Laboratories Inc.AbaxisInc. (a Zoetis company)Thermo Fisher Scientific Inc.Boehringer Ingelheim International GmbHMerial (now part of Boehringer Ingelheim)Biogal-Galed Labs Ltd.+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Veterinary Rapid Test Kit Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Veterinary Rapid Test Kit Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Veterinary Rapid Testing Kit Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportVeterinary Rapid Diagnostic Test Kit Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportVeterinary Rapid Diagnostic Assays Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportVeterinary Radiology Software Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportVeterinary Radiological System Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportVeterinary Radiography X-ray Generators Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportVeterinary Radiography Flat Panel Detectors Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportVeterinary Radiography Acquisition System Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportVeterinary Rabies Vaccine Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportVeterinary Pump Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportVeterinary Protective Boot Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportVeterinary Prosthetics and Orthotics Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.